Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) — Net Asset Quality Index
Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Net Asset Quality Index of 53.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.98 Billion minus total liabilities of CN¥927.34 Million yields net assets of CN¥1.05 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 002923 liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhuhai Rundu Pharmaceutical Co Ltd Class A Net Asset Quality Index Over Time (2011–2025)
This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 53.2%, representing net assets of CN¥1.05 Billion against total assets of CN¥1.98 Billion CNY. For live market cap and overall valuation, see Zhuhai Rundu Pharmaceutical Co Ltd Class stock valuation.
Annual Net Asset Quality Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Zhuhai Rundu Pharmaceutical Co Ltd Class's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.2% | CN¥1.04 Billion | CN¥2.03 Billion | CN¥990.19 Million | ▼ -1.3 pp |
| 2024 | 52.5% | CN¥1.15 Billion | CN¥2.19 Billion | CN¥1.04 Billion | ▼ -0.4 pp |
| 2023 | 52.9% | CN¥1.18 Billion | CN¥2.23 Billion | CN¥1.05 Billion | ▲ +0.6 pp |
| 2022 | 52.3% | CN¥1.20 Billion | CN¥2.29 Billion | CN¥1.09 Billion | ▼ -5.9 pp |
| 2021 | 58.2% | CN¥1.11 Billion | CN¥1.91 Billion | CN¥797.28 Million | ▼ -10.3 pp |
| 2020 | 68.6% | CN¥1.04 Billion | CN¥1.51 Billion | CN¥475.54 Million | ▼ -2.3 pp |
| 2019 | 70.9% | CN¥940.29 Million | CN¥1.33 Billion | CN¥386.39 Million | ▼ -5.7 pp |
| 2018 | 76.5% | CN¥871.29 Million | CN¥1.14 Billion | CN¥267.13 Million | ▲ +7.3 pp |
| 2017 | 69.2% | CN¥488.84 Million | CN¥706.00 Million | CN¥217.16 Million | ▲ +4.7 pp |
| 2016 | 64.6% | CN¥398.19 Million | CN¥616.60 Million | CN¥218.42 Million | ▲ +2.4 pp |
| 2015 | 62.2% | CN¥310.72 Million | CN¥499.72 Million | CN¥189.00 Million | ▼ -10.6 pp |
| 2014 | 72.8% | CN¥273.31 Million | CN¥375.41 Million | CN¥102.10 Million | ▲ +4.2 pp |
| 2013 | 68.6% | CN¥236.29 Million | CN¥344.54 Million | CN¥108.25 Million | ▲ +0.8 pp |
| 2012 | 67.8% | CN¥199.43 Million | CN¥294.06 Million | CN¥94.63 Million | ▼ -1.5 pp |
| 2011 | 69.3% | CN¥165.33 Million | CN¥238.62 Million | CN¥73.29 Million | — |